8-K: RGA Reports Strong Q4, Full-Year 2025 Earnings Growth

Reinsurance Group of America announced robust fourth-quarter and full-year 2025 financial results, driven by strong investment performance and diverse business segment contributions.

Summary

• Net income available to RGA shareholders for Q4 2025 was $463 million, or $6.97 per diluted share, a significant increase from $148 million, or $2.22 per diluted share, in Q4 2024.
• Adjusted operating income for Q4 2025 totaled $515 million, or $7.75 per diluted share, up from $334 million, or $4.99 per diluted share, in Q4 2024.
• Full-year 2025 net income available to RGA shareholders reached $1,182 million, or $17.69 per diluted share, compared to $717 million, or $10.73 per diluted share, in 2024.
• Full-year 2025 adjusted operating income was $1,518 million, or $22.72 per diluted share, an increase from $1,342 million, or $20.06 per diluted share, in 2024.
• Net premiums for Q4 2025 totaled $4.8 billion, representing a 15.0% increase over Q4 2024, with a favorable net foreign currency effect of $42 million.
• Full-year 2025 net premiums were $17.2 billion, a decrease of 3.4% from 2024, primarily due to lower single premium pension risk transfer transactions.
• The average investment yield was 5.23% in Q4 2025 and 4.99% for the full year 2025, reflecting higher new money rates and variable investment income.
• Estimated deployable capital stood at $3.4 billion at the end of 2025.
• The company repurchased $50 million of common shares in Q4 2025, contributing to a total of $125 million repurchased for the full year.
• The board of directors authorized a new share repurchase program for up to $500 million of common stock, effective January 29, 2026.
• A regular quarterly dividend of $0.93 per share was declared, payable March 3, 2026, to shareholders of record as of February 17, 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a very positive report, highlighting strong financial performance across key metrics, effective capital management through share repurchases, and an optimistic outlook from management, despite a slight dip in full-year net premiums.

Positives

• Net income available to RGA shareholders for Q4 2025 increased by 212% year-over-year to $463 million.
• Adjusted operating income for Q4 2025 grew by 54% year-over-year to $515 million.
• Full-year 2025 net income and adjusted operating income also showed substantial growth compared to 2024.
• Strong investment results, including favorable variable investment income and an increased average investment yield of 5.23% in Q4 2025.
• Net premiums in Q4 2025 increased by 15.0% to $4.8 billion.
• Most business segments contributed positively to results, highlighting the strength and diversity of the global platform.
• Financial metrics are tracking at or ahead of intermediate-term targets set in 2023.
• The company maintains a strong balance sheet and favorable business conditions.
• Estimated deployable capital of $3.4 billion provides flexibility for future strategic initiatives.
• A new $500 million share repurchase program was authorized, demonstrating a commitment to shareholder returns.
• The effective tax rate for Q4 2025 was 8.9%, below the expected range of 23% to 24%, primarily due to a release of a valuation allowance on investment portfolio tax assets.

Negatives

• Full-year 2025 net premiums decreased by 3.4% to $17.2 billion, primarily due to lower single premium pension risk transfer transactions compared to the prior year.
• The U.S. and Latin America Traditional segment's full-year results reflected unfavorable financial impact from individual life claims experience in capped cohorts and expected unfavorable group claims experience.
• The Canada Traditional segment's full-year results reflected unfavorable group experience.
• The EMEA Traditional segment's full-year results included $222 million of unfavorable impacts from the annual actuarial assumption review, categorized as notable items.
• The Corporate and Other segment's results were unfavorable compared to the expected quarterly average run rate, mainly due to higher general expenses and financing costs.

Risks

• Changes in mortality, morbidity, policyholder behavior, claims experience, investment returns, interest rates, and expenses compared to pricing assumptions.
• Investment results, whether from changes in economic, capitaland credit-market conditions, asset selection, or otherwise, and their impact on investment securities, liquidity, portfolio yields, credit quality, access to capital, cost of capital, and regulatory capital requirements.
• Changes in financial strength and credit ratings and their effect on the company.
• The availability, amount, cost, and market value of collateral necessary for regulatory reserves, capital, and client obligations.
• Changes in laws and regulations, tax policy and rates, accounting standards, and privacy, data security, and cybersecurity regulations applicable to the company, as well as actions by regulators.
• The impact of general economic conditions in the U.S. and globally, including as a result of inflation, interest rate levels, geopolitical instability, and impacts from tariffs.
• The stability and financial performance of clients, reinsurers, third-party investment managers, and other institutions.
• The effectiveness of risk management strategy, policy, and procedures.
• The impact of impairments of the value of investment securities on capital requirements and the subjectivity of impairment determinations.
• The threat of catastrophic events such as pandemics, epidemics, other major health issues, natural disasters, war, military actions, terrorism, or other acts of violence.
• Competitive factors and competitors' responses to initiatives.
• Development and introduction of new products and distribution opportunities and entry into new lines of business and markets.
• The impact of the development and adoption of artificial intelligence.
• The effect of acquisitions and other significant transactions, including risks related to integration and the ability to achieve expected benefits.
• Interruption or failure of telecommunication, information technology, or other operational systems, or failure to maintain adequate security for data and intellectual property.
• Adverse developments with respect to litigation, arbitration, or regulatory investigations or actions.
• Risks associated with international operations, including related to fluctuations in foreign currency exchange rates.

Future Outlook

CEO Tony Cheng expressed optimism for continued success, citing a strong balance sheet, favorable business conditions, and a proven strategy expected to yield attractive financial results over time. Financial metrics are tracking at or ahead of intermediate-term targets set in 2023, giving further confidence in meeting or exceeding established goals.

Management Comments

• "A very strong fourth quarter capped off another year of excellent financial results."
• "This was another quarter with positive contributions from most of our business segments, demonstrating the strength and diversity of our global platform and local teams."
• "Our financial metrics are tracking at or ahead of our targets, giving us further confidence that we will meet or exceed the established goals."
• "Our balance sheet is strong, business conditions are favorable, and we have a proven strategy that I expect to result in attractive financial results over time."

Industry Context

StockSavvy.ai notes that RGA's strong Q4 and full-year performance, particularly in adjusted operating income and investment yields, reflects a robust environment for life and health reinsurers capable of leveraging diverse global platforms. The increase in investment income, driven by higher new money rates, aligns with broader trends of rising interest rates benefiting insurance and reinsurance companies' investment portfolios. The strategic focus on in-force block transactions and capital deployment indicates a proactive approach to optimizing capital in a competitive landscape.

Comparison to Industry Standards

• The reported adjusted operating ROE of 14.7% (15.7% excluding notable items) for the trailing twelve months is competitive within the global reinsurance sector, often exceeding the average for diversified financial services firms.
• RGA's estimated deployable capital of $3.4 billion positions it strongly for future growth initiatives, including potential in-force block transactions, similar to how peers like Swiss Re and Munich Re maintain significant capital buffers for strategic opportunities and market resilience.
• The 15.0% increase in Q4 net premiums, while full-year premiums saw a slight decrease due to specific pension risk transfer dynamics, suggests a strong underlying demand for traditional reinsurance products, contrasting with some competitors who might be experiencing more stagnant premium growth in mature markets.

Stakeholder Impact

• Shareholders: Positive impact due to significantly increased net income and adjusted operating income, strong return on equity, a new substantial share repurchase program, and a declared quarterly dividend.
• Employees: Positive sentiment from the CEO's acknowledgment of the 'collective efforts of the global RGA team' in achieving strong results.
• Customers/Clients: Continued strong financial performance and substantial deployable capital indicate RGA's robust capacity to provide reliable financial solutions and effectively manage risk.
• Creditors: Strong financial results and a healthy balance sheet enhance the company's creditworthiness and ability to meet obligations.

Next Steps

• A conference call to discuss fourth quarter results will be held on Friday, February 6, 2026, at 10 a.m. Eastern Time.
• Share repurchases under the new $500 million authorization will be made in accordance with applicable securities laws, with timing and number of shares dependent on various factors.
• A regular quarterly dividend of $0.93 per share will be paid on March 3, 2026, to shareholders of record as of February 17, 2026.

Key Dates

Recommendation

The company delivered exceptionally strong Q4 and full-year results, significantly exceeding prior-year performance in net income and adjusted operating income. The robust investment income, healthy deployable capital, and a new substantial share repurchase authorization signal strong financial health and a commitment to shareholder returns. Management's optimistic outlook, backed by metrics tracking ahead of targets, further reinforces a positive investment thesis.

Keywords

Reinsurance, Life and Health Reinsurance, Financial Solutions, RGA, Earnings, Q4 2025, Full Year 2025, Net Income, Adjusted Operating Income, Share Repurchase, Dividend, Investment Income, Actuarial Assumptions, Corporate Governance, Risk Management, Capital Deployment, Pension Risk Transfer